Friday, March 30, 2012

My 2 Favorite Stocks for Next Week

My 2 Favorite Stocks for Next Week

The stock markets continued their upward trend this week, with just a little volatility. Indexes were aided by the great numbers posted by Michigan Sentiment, which came in at 76.2, compared to the 74.3 forecast.

As well, GDP (third estimate) remained steady at 3%, and personal spending rose. While unemployment claims were a bit higher than expected, they weren’t too far off the mark. Result: A decent end to the week.

Sector-wise, technology ruled the roost, with an average return of1.07% for the week, followed by Healthcare, at 0.90%.

The market continues to look undervalued to me, and my search this week found more than 40 companies that were worth a second look. Here are two of my favorites:

Glu Mobile (Nasdaq: GLUU) develops mobile games for the global market. Titles include: Big Time Gangsta, Blood & Glory, Bug Village, Contract Killer, Contract Killer: Zombies, Eternity Warriors, Frontline Commando, Gun Bros, Men vs. Machines, Stardom: The A-List, Super K.O. Boxing and Toyshop Adventures.

Price: $4.80
Market cap: $314.44 million
Target: $7.00 (conservative estimate)

Why I Like It: Discounted value, takeover candidate, and new analyst interest.

Merge Healthcare (Nasdaq: MRGE) sells software solutions that automate healthcare data and diagnostic workflow.

Price: $5.85
Market cap: $534.23 million
Target: $8.75

Why I Like It: Reported a good quarter, forming new business divisions, in a quick-growing sector, due to the need to create electronic patient records.

These stocks are both small-cap, so please understand that investing in them may entail more risk than buying shares in their larger competitors. Consequently, if you decide to purchase them, please make sure that they constitute only a small portion of your portfolio.

Note: I intend to establish a portfolio of similar picks, some 25-30 stocks that I’ll update on a regular basis. I will discuss them from time-to-time in my blog and on this web site, but a full analysis of each stock—as well as detailed updates—will be available only via subscription. If you’d like more information, just contact me directly, at

1 comment:

  1. awesome I put-off buying this for months, despite positive reviews.